• Quanterix Corp QTRX.OQ reported a quarterly adjusted loss of 30 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -33 cents. The mean expectation of six analysts for the quarter was for a loss of 25 cents per share. Wall Street expected results to range from -27 cents to -21 cents per share.

• Revenue rose 11.5% to $35.16 million from a year ago; analysts expected $34.44 million.

• Quanterix Corp's reported EPS for the quarter was a loss of 30 cents​.

• The company reported a quarterly loss of $11.63 million.

• Quanterix Corp shares had fallen by 33.6% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 10.1% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Quanterix Corp is $17.00

This summary was machine generated from LSEG data March 17 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)